Abstract
CMV infection can cause morbidity and mortality particularly in solid organ and haematological transplant patients. Prolonged antiviral prophylaxis or treatment increases risk for CMV antiviral resistance. We aimed to develop a CMV WGS approach using capture-probe hybridisation technology for high sensitivity detection of resistance mutations from plasma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
